{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T19:42:46Z","timestamp":1770579766645,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["Burulinox TMA 2016 SF-1509"],"award-info":[{"award-number":["Burulinox TMA 2016 SF-1509"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["Burulinox TMA 2016 SF-1509"],"award-info":[{"award-number":["Burulinox TMA 2016 SF-1509"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-03835-6","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T05:46:31Z","timestamp":1741153591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Improved protocols for isolation of Mycobacterium ulcerans from clinical samples"],"prefix":"10.1186","volume":"25","author":[{"given":"Bernadette","family":"Agbavor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rejoice Agyeiwaa","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail","family":"Agbanyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dzifa Kofi","family":"Ahiatrogah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charity Wiafe","family":"Akenten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Adu-Asiamah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kabiru Mohammed","family":"Abass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Ofori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Amofa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwadwo","family":"Boampong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Thye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew Glover","family":"Addo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Wansbrough-Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim John","family":"Bull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaw Ampem","family":"Amoako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard Odame","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"issue":"12","key":"3835_CR1","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.3201\/eid2512.190427","volume":"25","author":"TF Omansen","year":"2019","unstructured":"Omansen TF, Erbowor-Becksen A, Yotsu R, van der Werf TS, Tiendrebeogo A, Grout L, et al. Global epidemiology of buruli ulcer, 2010\u20132017, and analysis of 2014 WHO programmatic targets. Emerg Infect Dis. 2019;25(12):2183.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"3835_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s40475-018-0166-2","volume":"5","author":"RR Yotsu","year":"2018","unstructured":"Yotsu RR, Suzuki K, Simmonds RE, Bedimo R, Ablordey A, Yeboah-Manu D, et al. Buruli ulcer: a review of the current knowledge. Curr Trop Med Rep. 2018;5(4):247\u201356.","journal-title":"Curr Trop Med Rep"},{"key":"3835_CR3","unstructured":"WHO. Global health observatory data repository. World Health Organization; March 2015."},{"issue":"10","key":"3835_CR4","doi-asserted-by":"publisher","first-page":"e2463","DOI":"10.1371\/journal.pntd.0002463","volume":"7","author":"JA Trubiano","year":"2013","unstructured":"Trubiano JA, Lavender CJ, Fyfe JAM, Bittmann S, Johnson PDR. The incubation period of buruli ulcer (Mycobacterium ulcerans Infection). PLoS Negl Trop Dis. 2013;7(10):e2463.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"3835_CR5","doi-asserted-by":"publisher","first-page":"e0006323","DOI":"10.1371\/journal.pntd.0006323","volume":"12","author":"MJ Loftus","year":"2018","unstructured":"Loftus MJ, Trubiano JA, Tay EL, Lavender CJ, Globan M, Fyfe JAM, et al. The incubation period of buruli ulcer (Mycobacterium ulcerans infection) in Victoria, Australia\u2013 Remains similar despite changing geographic distribution of disease. PLoS Negl Trop Dis. 2018;12(3):e0006323.","journal-title":"PLoS Negl Trop Dis"},{"key":"3835_CR6","unstructured":"Phillips RO, Robert J, Abass KM, Thompson W, Sarfo FS, Wilson T et al. Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial. Lancet. 2020."},{"key":"3835_CR7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/978-3-030-89704-8_45","volume-title":"Leprosy and buruli ulcer: A practical guide","author":"TS van der Werf","year":"2022","unstructured":"van der Werf TS, Phillips RO, Johnson RC, Barogui YT. Treatment of buruli ulcer. In: Nunzi E, Massone C, Portaels F, editors. Leprosy and buruli ulcer: A practical guide. Cham: Springer International Publishing; 2022. pp. 509\u201327."},{"issue":"11","key":"3835_CR8","doi-asserted-by":"publisher","first-page":"e0010908","DOI":"10.1371\/journal.pntd.0010908","volume":"16","author":"E Marion","year":"2022","unstructured":"Marion E, Hycenth N, Vedithi SC, Robbe-Saule M, Donkeng V, Ganlonon L-M, et al. A combined effort of 11 laboratories in the WHO African region to improve quality of buruli ulcer PCR diagnosis: the BU-LABNET. PLoS Negl Trop Dis. 2022;16(11):e0010908.","journal-title":"PLoS Negl Trop Dis"},{"key":"3835_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-3-030-11114-4_10","volume-title":"Laboratory diagnosis of buruli ulcer: challenges and future perspectives","author":"K R\u00f6ltgen","year":"2019","unstructured":"R\u00f6ltgen K, Cruz I, Ndung\u2019u JM, Pluschke G. Laboratory diagnosis of buruli ulcer: challenges and future perspectives. Buruli Ulcer: Springer; 2019. pp. 183\u2013202."},{"key":"3835_CR10","doi-asserted-by":"crossref","unstructured":"Sakyi SA, Aboagye SY, Darko Otchere I, Yeboah-Manu D. Clinical and laboratory diagnosis of Buruli ulcer disease: a systematic review. Canadian Journal of Infectious Diseases and Medical Microbiology. 2016;2016.","DOI":"10.1155\/2016\/5310718"},{"key":"3835_CR11","unstructured":"Portaels F, Organization WH. Laboratory diagnosis of buruli ulcer: a manual for health care providers. World Health Organization; 2014. p. 9241505702. Report No."},{"key":"3835_CR12","unstructured":"W.H.O. Treatment of Mycobacterium ulcerans disease (Buruli ulcer): guidance for health workers. 2012."},{"issue":"9715","key":"3835_CR13","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/S0140-6736(09)61962-0","volume":"375","author":"WA Nienhuis","year":"2010","unstructured":"Nienhuis WA, Stienstra Y, Thompson WA, Awuah PC, Abass KM, Tuah W, et al. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial. Lancet. 2010;375(9715):664\u201372.","journal-title":"Lancet"},{"issue":"9","key":"3835_CR14","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1128\/AAC.00299-10","volume":"54","author":"Fred Stephen Sarfo","year":"2010","unstructured":"Sarfo FS, Phillips R, Asiedu K, Ampadu E, Bobi N, Adentwe E et al. Clinical efficacy of combination of Rifampin and streptomycin for treatment of Mycobacterium ulcerans disease. Antimicrob Agents Chemother. 2010;54(9):3678\u201385. https:\/\/pubmed.ncbi.nlm.nih.gov\/20566765\/","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3835_CR15","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1128\/AAC.02165-13","volume":"58","author":"RO Phillips","year":"2014","unstructured":"Phillips RO, Sarfo FS, Abass MK, Abotsi J, Wilson T, Forson M, et al. Clinical and bacteriological efficacy of Rifampin-streptomycin combination for two weeks followed by Rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease. Antimicrob Agents Chemother. 2014;58(2):1161\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"3835_CR16","doi-asserted-by":"publisher","first-page":"e422","DOI":"10.1016\/S2214-109X(14)70223-2","volume":"2","author":"QB Vincent","year":"2014","unstructured":"Vincent QB, Ardant M-F, Adeye A, Goundote A, Saint-Andr\u00e9 J-P, Cottin J, et al. Clinical epidemiology of laboratory-confirmed buruli ulcer in Benin: a cohort study. Lancet Global Health. 2014;2(7):e422\u201330.","journal-title":"Lancet Global Health"},{"issue":"1","key":"3835_CR17","doi-asserted-by":"publisher","first-page":"e3457","DOI":"10.1371\/journal.pntd.0003457","volume":"9","author":"RO Phillips","year":"2015","unstructured":"Phillips RO, Phanzu DM, Beissner M, Badziklou K, Luzolo EK, Sarfo FS, et al. Effectiveness of routine BCG vaccination on buruli ulcer disease: a case-control study in the Democratic Republic of congo, Ghana and Togo. PLoS Negl Trop Dis. 2015;9(1):e3457.","journal-title":"PLoS Negl Trop Dis"},{"key":"3835_CR18","doi-asserted-by":"publisher","first-page":"100415","DOI":"10.1016\/j.jctube.2024.100415","volume":"34","author":"B Agbavor","year":"2024","unstructured":"Agbavor B, Agbanyo A, Loglo AD, Antwi PB, Ackam N, Adjei J, et al. Clinical and Microbiological predictors of healing in buruli ulcer disease. J Clin Tuberc Other Mycobact Dis. 2024;34:100415.","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"3835_CR19","doi-asserted-by":"crossref","unstructured":"Frimpong M, Agbavor B, Duah MS, Loglo A, Sarpong FN, Boakye-Appiah J et al. Paradoxical reactions in buruli ulcer after initiation of antibiotic therapy: relationship to bacterial load. PLoS Negl Trop Dis. 2019;13(8).","DOI":"10.1371\/journal.pntd.0007689"},{"issue":"2","key":"3835_CR20","first-page":"281","volume":"15","author":"R Peres","year":"2011","unstructured":"Peres R, Palaci M, Loureiro R, Dietze R, Johnson J, Maciel E. Reduction of contamination of mycobacterial growth indicator tubes using increased PANTA concentration. Int J Tuberc Lung Dis. 2011;15(2):281\u20133.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"3835_CR21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s12879-014-0636-7","volume":"14","author":"MW Bratschi","year":"2014","unstructured":"Bratschi MW, Bolz M, Grize L, Kerber S, Minyem JC, Um Boock A, et al. Primary cultivation: factors affecting contamination and Mycobacterium ulcerans growth after long turnover time of clinical specimens. BMC Infect Dis. 2014;14(1):636.","journal-title":"BMC Infect Dis"},{"key":"3835_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-015-0479-4","volume":"15","author":"S Asmar","year":"2015","unstructured":"Asmar S, Drancourt M. Chlorhexidine decontamination of sputum for culturing Mycobacterium tuberculosis. BMC Microbiol. 2015;15:1\u20136.","journal-title":"BMC Microbiol"},{"issue":"2","key":"3835_CR23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1128\/JCM.36.2.402-408.1998","volume":"36","author":"J Palomino","year":"1998","unstructured":"Palomino J, Portaels F. Effects of decontamination methods and culture conditions on viability of Mycobacterium ulcerans in the BACTEC system. J Clin Microbiol. 1998;36(2):402\u20138.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"3835_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12866-016-0918-x","volume":"17","author":"E Owusu","year":"2017","unstructured":"Owusu E, Newman MJ, Akumwena A, Bannerman E, Pluschke G. Evaluating decontamination protocols for the isolation of Mycobacterium ulcerans from swabs. BMC Microbiol. 2017;17(1):2.","journal-title":"BMC Microbiol"},{"issue":"1","key":"3835_CR25","doi-asserted-by":"publisher","first-page":"6778","DOI":"10.1038\/s41598-018-25278-y","volume":"8","author":"D Zingue","year":"2018","unstructured":"Zingue D, Panda A, Drancourt M. A protocol for culturing environmental strains of the buruli ulcer agent, Mycobacterium ulcerans. Sci Rep. 2018;8(1):6778.","journal-title":"Sci Rep"},{"issue":"2","key":"3835_CR26","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1264\/jsme2.ME17160","volume":"33","author":"D Sanhueza","year":"2018","unstructured":"Sanhueza D, Chevillon C, Bouzinbi N, Godreuil S, Gu\u00e9gan J-F. Chitin increases Mycobacterium ulcerans growth in acidic environments. Microbes Environ. 2018;33(2):234\u20137.","journal-title":"Microbes Environ"},{"issue":"12","key":"3835_CR27","doi-asserted-by":"publisher","first-page":"5875","DOI":"10.1128\/JCM.42.12.5875-5876.2004","volume":"42","author":"D Yeboah-Manu","year":"2004","unstructured":"Yeboah-Manu D, Bodmer T, Mensah-Quainoo E, Owusu S, Ofori-Adjei D, Pluschke G. Evaluation of decontamination methods and growth media for primary isolation of Mycobacterium ulcerans from surgical specimens. J Clin Microbiol. 2004;42(12):5875\u20136.","journal-title":"J Clin Microbiol"},{"key":"3835_CR28","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.3389\/fmicb.2016.02112","volume":"7","author":"TJ Bull","year":"2017","unstructured":"Bull TJ, Munshi T, Mikkelsen H, Hartmann SB, S\u00f8rensen MR, Garcia JS, et al. Improved culture medium (Tika) for Mycobacterium avium subspecies paratuberculosis (MAP) matches qPCR sensitivity and reveals significant proportions of non-viable MAP in lymphoid tissue of vaccinated MAP challenged animals. Front Microbiol. 2017;7:2112.","journal-title":"Front Microbiol"},{"issue":"1","key":"3835_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41598-023-50236-8","volume":"14","author":"R Dwyer","year":"2024","unstructured":"Dwyer R, Witte C, Buss P, Warren R, Miller M, Goosen W. Antemortem detection of Mycobacterium bovis in nasal swabs from African rhinoceros. Sci Rep. 2024;14(1):357.","journal-title":"Sci Rep"},{"issue":"6","key":"3835_CR30","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3390\/pathogens11060709","volume":"11","author":"WJ Goosen","year":"2022","unstructured":"Goosen WJ, Clarke C, Kleynhans L, Kerr TJ, Buss P, Miller MA, Culture-Independent PCR. Detection and differentiation of mycobacteria spp. In antemortem respiratory samples from African elephants (Loxodonta Africana) and Rhinoceros (Ceratotherium Simum, Diceros Bicornis) In South Africa. Pathogens. 2022;11(6):709.","journal-title":"Pathogens"},{"issue":"1","key":"3835_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/10406387211044192","volume":"34","author":"WJ Goosen","year":"2022","unstructured":"Goosen WJ, Kleynhans L, Kerr TJ, van Helden PD, Buss P, Warren RM, et al. Improved detection of Mycobacterium tuberculosis and M. bovis in African wildlife samples using cationic peptide decontamination and mycobacterial culture supplementation. J Vet Diagn Invest. 2022;34(1):61\u20137.","journal-title":"J Vet Diagn Invest"},{"issue":"24","key":"3835_CR32","doi-asserted-by":"publisher","first-page":"17555","DOI":"10.3390\/ijms242417555","volume":"24","author":"TJ Bull","year":"2023","unstructured":"Bull TJ, Munshi T, Lopez-Perez PM, Tran AC, Cosgrove C, Bartolf A, et al. Specific cationic antimicrobial peptides enhance the recovery of Low-Load quiescent Mycobacterium tuberculosis in routine diagnostics. Int J Mol Sci. 2023;24(24):17555.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"3835_CR33","doi-asserted-by":"publisher","first-page":"e0005695","DOI":"10.1371\/journal.pntd.0005695","volume":"11","author":"M Sarpong-Duah","year":"2017","unstructured":"Sarpong-Duah M, Frimpong M, Beissner M, Saar M, Laing K, Sarpong F, et al. Clearance of viable Mycobacterium ulcerans from buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase\/is 2404 qPCR assay. PLoS Negl Trop Dis. 2017;11(7):e0005695.","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"3835_CR34","doi-asserted-by":"publisher","first-page":"e0007689","DOI":"10.1371\/journal.pntd.0007689","volume":"13","author":"M Frimpong","year":"2019","unstructured":"Frimpong M, Agbavor B, Duah MS, Loglo A, Sarpong FN, Boakye-Appiah J, et al. Paradoxical reactions in buruli ulcer after initiation of antibiotic therapy: relationship to bacterial load. PLoS Negl Trop Dis. 2019;13(8):e0007689.","journal-title":"PLoS Negl Trop Dis"},{"key":"3835_CR35","doi-asserted-by":"crossref","unstructured":"Wallace E, Hendrickson D, Tolli N, Mehaffy C, Pe\u00f1a M, Nick JA et al. Culturing mycobacteria. Mycobact Protocols. 2021:1\u201358.","DOI":"10.1007\/978-1-0716-1460-0_1"},{"key":"3835_CR36","unstructured":"Portaels Fo, Johnson P, Meyers WM, Organization WH, Initiative GBU. Buruli ulcer: diagnosis of Mycobacterium ulcerans disease: a manual for health care providers. World Health Organization; 2001."},{"key":"3835_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-0716-1779-3_3","volume-title":"Mycobacterium ulcerans: methods and protocols","author":"D Yeboah-Manu","year":"2022","unstructured":"Yeboah-Manu D, Asante-Poku A, Yaw Aboagye S. Primary isolation of Mycobacterium ulcerans. In: Pluschke G, R\u00f6ltgen K, editors. Mycobacterium ulcerans: methods and protocols. New York, NY: Springer US; 2022. pp. 17\u201328."},{"issue":"4","key":"3835_CR38","doi-asserted-by":"publisher","first-page":"e0284201","DOI":"10.1371\/journal.pone.0284201","volume":"18","author":"B Tweedale","year":"2023","unstructured":"Tweedale B, Collier F, Waidyatillake NT, Athan E, O\u2019Brien DP. Mycobacterium ulcerans culture results according to duration of prior antibiotic treatment: A cohort study. PLoS ONE. 2023;18(4):e0284201.","journal-title":"PLoS ONE"},{"issue":"1","key":"3835_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-020-02070-5","volume":"21","author":"E Gyamfi","year":"2021","unstructured":"Gyamfi E, Narh CA, Quaye C, Abbass A, Dzudzor B, Mosi L. Microbiology of secondary infections in buruli ulcer lesions; implications for therapeutic interventions. BMC Microbiol. 2021;21(1):1\u201312.","journal-title":"BMC Microbiol"},{"key":"3835_CR40","doi-asserted-by":"crossref","unstructured":"Kpeli GS, Yeboah-Manu D. Secondary infection of Buruli ulcer lesions. Buruli Ulcer: Mycobacterium Ulcerans Disease. 2019:227\u2013\u200939.","DOI":"10.1007\/978-3-030-11114-4_13"},{"key":"3835_CR41","doi-asserted-by":"crossref","unstructured":"Yeboah-Manu D, Kpeli GS, Ruf M-T, Asan-Ampah K, Quenin-Fosu K, Owusu-Mireku E et al. Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin. PLoS Negl Trop Dis. 2013;7(5).","DOI":"10.1371\/journal.pntd.0002191"},{"issue":"12","key":"3835_CR42","first-page":"1572","volume":"13","author":"R Peres","year":"2009","unstructured":"Peres R, Maciel E, Morais C, Ribeiro F, Vinhas S, Pinheiro C, et al. Comparison of two concentrations of NALC-NaOH for decontamination of sputum for mycobacterial culture. Int J Tuberc Lung Dis. 2009;13(12):1572\u20135.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"3835_CR43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1128\/JCM.00301-07","volume":"46","author":"M Eddyani","year":"2008","unstructured":"Eddyani M, Debacker M, Martin A, Aguiar J, Johnson CR, Uwizeye C, et al. Primary culture of Mycobacterium ulcerans from human tissue specimens after storage in semisolid transport medium. J Clin Microbiol. 2008;46(1):69\u201372.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"3835_CR44","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1128\/JCM.02279-10","volume":"49","author":"D Yeboah-Manu","year":"2011","unstructured":"Yeboah-Manu D, Danso E, Ampah K, Asante-Poku A, Nakobu Z, Pluschke G. Isolation of Mycobacterium ulcerans from swab and Fine-Needle-Aspiration specimens. J Clin Microbiol. 2011;49(5):1997\u20139.","journal-title":"J Clin Microbiol"},{"key":"3835_CR45","doi-asserted-by":"publisher","first-page":"650","DOI":"10.2471\/BLT.08.050955","volume":"86","author":"JR Williams","year":"2008","unstructured":"Williams JR. The declaration of Helsinki and public health. Bull World Health Organ. 2008;86:650\u20132.","journal-title":"Bull World Health Organ"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03835-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-03835-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03835-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:03:56Z","timestamp":1741349036000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-03835-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3835"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-03835-6","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"28 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"was sought from the Committee on Human Research, Publications and Ethics (CHRPE) (CHRPE\/AP\/472\/17) of the Kwame Nkrumah University of Science and Technology (KNUST). Written informed consent was obtained from willing participants. Full disclosure and explanation of the study procedures was provided to all participants in a language of their choice (this was largely English or the local language, Twi). For individuals who could not read or understand English, consenting was done via an interpreter in the presence of a witness of the individual\u2019s choice. Following this, persons could sign or were thumb-printed to provide consent for inclusion in the study. For young children (<\u200918 years), written consent was obtained from parents or legal guardians. All the study processes were conducted in accordance with the principles guiding research in human subjects as set out in the Declaration of Helsinki [].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"118"}}